Citigroup Inc Apellis Pharmaceuticals, Inc. Transaction History

Citigroup Inc

$217 Billion
Q3 2025

A detailed history of Citigroup Inc transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Citigroup Inc holds 444,972 shares of APLS stock, worth $9.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

444,972

Previous 138,451 221.39%

Holding current value

$9.05 Million

Previous $2.4 Million 320.24%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	BUY	$17.42 - $28.65 $5.34 Million - $8.78 Million	306,521 Added 221.39%	444,972 $10.1 Million
Q2 2025 Aug 11, 2025	SELL	$16.36 - $23.0 $4.55 Million - $6.4 Million	-278,168 Reduced 66.77%	138,451 $2.4 Million
Q1 2025 May 12, 2025	BUY	$21.87 - $34.63 $4.91 Million - $7.77 Million	224,458 Added 116.81%	416,619 $9.11 Million
Q4 2024 Feb 12, 2025	BUY	$26.18 - $35.42 $4.71 Million - $6.38 Million	179,999 Added 1480.01%	192,161 $6.13 Million
Q3 2024 Nov 12, 2024	SELL	$28.84 - $41.15 $879,821 - $1.26 Million	-30,507 Reduced 71.5%	12,162 $350,000

Q2 2024 Aug 12, 2024	SELL	$38.07 - $59.71 $8.34 Million - $13.1 Million	-219,039 Reduced 83.7%	42,669 $1.64 Million
Q1 2024 May 10, 2024	BUY	$55.39 - $72.47 $9.7 Million - $12.7 Million	175,167 Added 202.41%	261,708 $15.4 Million
Q4 2023 Feb 09, 2024	SELL	$37.14 - $64.82 $1.13 Million - $1.97 Million	-30,355 Reduced 25.97%	86,541 $5.18 Million
Q3 2023 Nov 09, 2023	BUY	$23.65 - $89.22 $872,945 - $3.29 Million	36,911 Added 46.15%	116,896 $4.45 Million
Q2 2023 Aug 10, 2023	SELL	$76.68 - $93.31 $3.33 Million - $4.05 Million	-43,422 Reduced 35.19%	79,985 $7.29 Million
Q1 2023 May 11, 2023	BUY	$46.59 - $66.96 $1.92 Million - $2.77 Million	41,307 Added 50.31%	123,407 $8.14 Million
Q4 2022 Feb 09, 2023	SELL	$43.24 - $61.04 $680,251 - $960,281	-15,732 Reduced 16.08%	82,100 $4.25 Million
Q3 2022 Nov 10, 2022	SELL	$44.76 - $69.66 $184,769 - $287,556	-4,128 Reduced 4.05%	97,832 $6.68 Million
Q2 2022 Aug 10, 2022	BUY	$35.07 - $59.21 $2.64 Million - $4.46 Million	75,276 Added 282.1%	101,960 $4.61 Million
Q1 2022 May 12, 2022	SELL	$35.46 - $54.12 $3.3 Million - $5.03 Million	-93,004 Reduced 77.71%	26,684 $1.36 Million
Q4 2021 Feb 10, 2022	BUY	$30.74 - $49.16 $1.52 Million - $2.43 Million	49,396 Added 70.27%	119,688 $5.66 Million
Q3 2021 Nov 10, 2021	BUY	$31.4 - $69.84 $2.21 Million - $4.91 Million	70,292 New	70,292 $2.32 Million

Others Institutions Holding APLS

# of Institutions

330

Shares Held

124M

Call Options Held

4.15M

Put Options Held

769K

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.23B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account